CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cordlife Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cordlife Group Ltd
1 Yishun Industrial Street 1
A'Posh Bizhub, # 06 01 09
Phone: +65 62380808p:+65 62380808 768160  Singapore Ticker: P8AP8A
Business Summary
Cordlife Group Limited is a Singapore-based company that owns cord blood banks across Asia, including Hong Kong, Indonesia, the Philippines, India, and Malaysia. The Company's principal activities involve investment holding and the provision of cord blood banking services. Its segments include Banking and Diagnostics. The Banking segment comprises of the banking of samples such as cord blood, cord lining and cord tissue. Cord blood, cord lining and cord tissue are collected, processed, and stored in the various laboratories. The Diagnostics segment comprises diagnostic testing such as non-invasive prenatal testing service, newborn metabolic screening, newborn genetic screening, and pediatric vision screening services. Its subsidiaries include Cordlife (Hong Kong) Limited, Cordlife Stem Cell Technology Limited, Healthbaby Biotech (Hong Kong) Co., Limited, Cordlife Technologies Pte. Ltd., CS Cell Technologies Pte. Ltd., Stemlife Berhad, and Shanghai Cordlife Biomedical Research Co., Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
8099 Health and allied services, not elsewhere classified
8071 Medical laboratories
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board LingyunZhai 52 6/16/2025 12/12/2019
Group Chief Executive Officer, Group Executive Director XiaolingChen 34 6/5/2025 12/1/2021
Group Chief Financial Officer Hnin YiThet 46 1/16/2023
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
StemLife Berhad B-7-15 KUALA LUMPUR Malaysia

Business Names
Business Name
Cordlife Stem Cell Technology Limited
CS Cell Technologies Pte. Ltd
Healthbaby Biotech (Hong Kong) Co. Limited
P.T. Cordlife Indonesia
P8A
StemLife Berhad

General Information
Number of Employees: 111 (As of 6/30/2011)
Outstanding Shares: 256,307,354 (As of 12/31/2024)
Shareholders: 1,474
Stock Exchange: SIN
Fax Number: +65 62381108


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, July 7, 2025